Stockscreener 앱 받기
0.2946
10.92%
-0.0361
전일 마감가:
$0.3307
열려 있는:
$0.3268
하루 거래량:
786.49K
Relative Volume:
0.08
시가총액:
$14.67M
수익:
$62.71M
순이익/손실:
$-10.48M
주가수익비율:
-0.4676
EPS:
-0.63
순현금흐름:
$-13.77M
1주 성능:
-15.90%
1개월 성능:
+22.75%
6개월 성능:
-85.84%
1년 성능:
-94.56%
1일 변동 폭
$0.2943
$0.3336
1주일 범위
$0.2943
$0.3551
52주 변동 폭
$0.2179
$5.62
프로페이즈 Stock (PRPH) Company Profile
명칭
Prophase Labs Inc
전화
(215) 345-0919
주소
711 STEWART AVE, SUITE 200, NEW YORK, PA
PRPH을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
PRPH
Prophase Labs Inc
|
0.2946 | 14.67M | 62.71M | -10.48M | -13.77M | -0.63 |
|
TMO
Thermo Fisher Scientific Inc
|
422.27 | 159.05B | 42.90B | 6.52B | 6.72B | 17.05 |
|
DHR
Danaher Corp
|
197.40 | 140.21B | 23.82B | 3.77B | 4.90B | 5.15 |
|
IDXX
Idexx Laboratories Inc
|
475.07 | 34.90B | 3.93B | 894.97M | 837.70M | 10.82 |
|
A
Agilent Technologies Inc
|
108.37 | 30.47B | 6.53B | 1.26B | 1.31B | 4.35 |
|
IQV
Iqvia Holdings Inc
|
152.30 | 26.47B | 15.41B | 1.37B | 2.11B | 7.50 |
프로페이즈 Stock (PRPH) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2021-12-20 | 개시 | H.C. Wainwright | Buy |
| 2021-10-13 | 다운그레이드 | Dawson James | Buy → Neutral |
| 2021-01-20 | 개시 | Dawson James | Buy |
프로페이즈 주식(PRPH)의 최신 뉴스
Geode Capital Management LLC Boosts Stake in ProPhase Labs, Inc. (NASDAQ:PRPH) - Defense World
ProPhase Labs, Inc. (NASDAQ:PRPH) Q4 2024 Earnings Call Transcript - MSN
PRPH’s Stock Market Puzzle: Piecing Together 2023’s Performance - investchronicle.com
There is no doubt that ProPhase Labs Inc (PRPH) ticks all the boxes. - Sete News
Metric Analysis: ProPhase Labs Inc (PRPH)’s Key Ratios in the Limelight - DWinneX
What was ProPhase Labs Inc (PRPH)’s performance in the last session? - uspostnews.com
Press Release Distribution & PR Platform - ACCESS Newswire
ProPhase Labs Inc (PRPH) is a good investment, but the stock may be overvalued - uspostnews.com
Daily Market Movement: ProPhase Labs Inc (PRPH) Sees a 0.54 Increase, Closing at 0.35 - DWinneX
Monitoring ProPhase Labs Inc (PRPH) after recent insider movements - knoxdaily.com
ProPhase Labs Inc (PRPH) Stock: Navigating Market Highs and Lows in 52 Weeks - investchronicle.com
Investors Take Advantage Of 7.67% Gain In ProPhase Labs Inc (NASDAQ: PRPH) - Stocksregister
Form 424B5Prospectus [Rule 424(b)(5)] - ADVFN
ProPhase Labs, Inc. (NASDAQ:PRPH) Short Interest Up 50.0% in March - Defense World
ProPhase Labs Closes $23.6M Asset Sale to Streamline Business Strategy - citybuzz -
ProPhase Labs Inc (NASDAQ: PRPH): Forecast Weak In 2025, Up -95.29% - Stocksregister
HighTower Advisors LLC Acquires 57,736 Shares of ProPhase Labs, Inc. (NASDAQ:PRPH) - Defense World
ProPhase Labs Inc (PRPH) Q4 2024 Earnings Call Highlights: Strategic Moves and Financial Challenges By GuruFocus - Investing.com Canada
ProPhase Labs Inc (PRPH) Q4 2024 Earnings Call Highlights: Strategic Moves and Financial Challenges - Yahoo Finance
A Tale of Resilience: ProPhase Labs Inc Amid Stock Market Turbulence - investchronicle.com
ProPhase Labs Inc (PRPH) Q4 2024 Earnings Call Highlights: Strat - GuruFocus
ProPhase Labs Delays Yearly Report Filing - TipRanks
Prophase Labs Inc reports results for the quarter ended December 31Earnings Summary - TradingView
ProPhase Labs, Inc. SEC 10-K Report - TradingView
ProPhase Labs Reports 2024 Financial Results and Strategic Shift - TipRanks
Earnings call transcript: ProPhase Labs Q4 2024 earnings miss, stock falls - Investing.com Australia
ProPhase Labs earnings missed by $1.62, revenue topped estimates - Investing.com Canada
Earnings call transcript: ProPhase Labs Q4 2024 earnings miss, stock falls By Investing.com - Investing.com Canada
ProPhase Labs Inc Reports $6.8 Million Revenue and $(2.61) EPS f - GuruFocus
ProPhase Labs, Inc. Announces Financial Results for the Year Ended December 31, 2024 - The Manila Times
ProPhase Labs Pivots Business Model After $53M Loss: Cancer Test Launch Takes Center Stage - Stock Titan
ProPhase Labs (PRPH) Set to Announce FY Earnings, Faces Challenges - GuruFocus.com
An Overview of ProPhase Labs's Earnings - Benzinga
ProPhase Labs Inc. to Present 2024 Year End Financial Results on March 31, 2025 - The Manila Times
ProPhase Labs Announces Key Full Year 2024 Financial Results PresentationVirtual Access Available - Stock Titan
12 Health Care Stocks Moving In Tuesday's Intraday Session - Benzinga
12 Health Care Stocks Moving In Monday's Pre-Market Session - Benzinga
ProPhase Labs (PRPH) Projected to Post Earnings on Thursday - Defense World
ProPhase Labs, Inc. CEO Ted Karkus to Present at Q1 Investor Summit Virtual on March 11th - Nasdaq
ProPhase Labs to Present at the Investor Summit Virtual on March 11 - GlobeNewswire
Can ProPhase Labs Convince Investors? CEO Reveals Strategic Vision Next Week - StockTitan
Bears are Losing Control Over ProPhase Labs (PRPH), Here's Why It's a 'Buy' Now - Yahoo Finance
ProPhase Labs, Inc. to Host Earnings Call - ACCESS Newswire
Diamond Equity Research Releases Update Note on ProPhase Labs Inc. (NASDAQ: PRPH) - EIN News
Deeper Dive: Understanding ProPhase Labs Inc (PRPH) Through its Various Ratios - The Dwinnex
ProPhase Labs Examines Strategic Opportunities to Leverage - GlobeNewswire
ProPhase Labs Focuses On Telehealth And DTC Marketing For Prescription Drug Growth Strategy - Nasdaq
ProPhase Labs examines opportunities to leverage DTC multi-media infrastructure - TipRanks
ProPhase Labs Examines Strategic Opportunities to Leverage Its DTC Multi-Media Infrastructure with Telehealth Physician Networks for Prescription Drugs - The Manila Times
Can ProPhase's Telehealth Pivot Save Its Stock From Delisting? Company Says No Reverse Split Needed - StockTitan
ProPhase Labs (NASDAQ:PRPH) Now Covered by Analysts at StockNews.com - Defense World
프로페이즈 (PRPH) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.34%
0.46%
자본화:
|
볼륨(24시간):